Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous Abstract"In vivo percutaneous absorption studies of volatile organic solvents in hairless mice. II. Toluene, ethylbenzene and aniline"    Next AbstractMonitoring spatial distribution of ethanol in microfluidic channels by using a thin layer of cholesteric liquid crystal »

Metabolites


Title:Lipid Peroxidation Produces a Diverse Mixture of Saturated and Unsaturated Aldehydes in Exhaled Breath That Can Serve as Biomarkers of Lung Cancer-A Review
Author(s):Sutaria SR; Gori SS; Morris JD; Xie Z; Fu XA; Nantz MH;
Address:"Department of Chemistry, University of Louisville, Louisville, KY 40292, USA. Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA. Department of Chemical Engineering, University of Louisville, Louisville, KY 40292, USA"
Journal Title:Metabolites
Year:2022
Volume:20220618
Issue:6
Page Number: -
DOI: 10.3390/metabo12060561
ISSN/ISBN:2218-1989 (Print) 2218-1989 (Electronic) 2218-1989 (Linking)
Abstract:"The peroxidation of unsaturated fatty acids is a widely recognized metabolic process that creates a complex mixture of volatile organic compounds including aldehydes. Elevated levels of reactive oxygen species in cancer cells promote random lipid peroxidation, which leads to a variety of aldehydes. In the case of lung cancer, many of these volatile aldehydes are exhaled and are of interest as potential markers of the disease. Relevant studies reporting aldehydes in the exhaled breath of lung cancer patients were collected for this review by searching the PubMed and SciFinder(n) databases until 25 May 2022. Information on breath test results, including the biomarker collection, preconcentration, and quantification methods, was extracted and tabulated. Overall, 44 studies were included spanning a period of 34 years. The data show that, as a class, aldehydes are significantly elevated in the breath of lung cancer patients at all stages of the disease relative to healthy control subjects. The type of aldehyde detected and/or deemed to be a biomarker is highly dependent on the method of exhaled breath sampling and analysis. Unsaturated aldehydes, detected primarily when derivatized during preconcentration, are underrepresented as biomarkers given that they are also likely products of lipid peroxidation. Pentanal, hexanal, and heptanal were the most reported aldehydes in studies of exhaled breath from lung cancer patients"
Keywords:Voc aldehyde biomarker breath analysis exhaled breath lipid peroxidation lung cancer unsaturated;
Notes:"PubMed-not-MEDLINESutaria, Saurin R Gori, Sadakatali S Morris, James D Xie, Zhenzhen Fu, Xiao-An Nantz, Michael H eng Review Switzerland 2022/06/24 Metabolites. 2022 Jun 18; 12(6):561. doi: 10.3390/metabo12060561"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 26-12-2024